RxSight, Inc. (RXST) stock
RXSTNasdaqOphthalmic GoodsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 10/3076% below fair value
$4.83−0.47 (-8.87%)
Close on Nov 17, 2026Market cap $200.90MP/E –Yield –
RxSight operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
RxSight's operating cash flow for the twelve months ending Jun 30, 2026 was -$22.73M. For fiscal 2025 it was -$15.51M. The highest annual figure on record is -$15.51M in fiscal 2025.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$15.51M | – |
| FY2024 | Dec 31, 2024 | -$16.95M | – |
| FY2023 | Dec 31, 2023 | -$41.59M | – |
| FY2022 | Dec 31, 2022 | -$58.85M | – |
| FY2021 | Dec 31, 2021 | -$44.71M | – |
| FY2020 | Dec 31, 2020 | -$35.20M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$9.54M | – |
| Q1 FY2026 | Mar 31, 2026 | -$10.89M | – |
| Q4 FY2025 | Dec 31, 2025 | -$1.12M | – |
| Q3 FY2025 | Sep 30, 2025 | -$1.19M | -282.6% |
| Q2 FY2025 | Jun 30, 2025 | -$4.38M | – |
| Q1 FY2025 | Mar 31, 2025 | -$8.83M | – |
| Q4 FY2024 | Dec 31, 2024 | -$4.26M | – |
| Q3 FY2024 | Sep 30, 2024 | $650.00K | – |
| Q2 FY2024 | Jun 30, 2024 | -$4.03M | – |
| Q1 FY2024 | Mar 31, 2024 | -$9.31M | – |
| Q4 FY2023 | Dec 31, 2023 | -$8.30M | – |
| Q3 FY2023 | Sep 30, 2023 | -$7.98M | – |
| Q2 FY2023 | Jun 30, 2023 | -$7.55M | – |
| Q1 FY2023 | Mar 31, 2023 | -$17.76M | – |
| Q4 FY2022 | Dec 31, 2022 | -$13.85M | – |
| Q3 FY2022 | Sep 30, 2022 | -$15.19M | – |
| Q2 FY2022 | Jun 30, 2022 | -$14.82M | – |
| Q1 FY2022 | Mar 31, 2022 | -$14.99M | – |
| Q4 FY2021 | Dec 31, 2021 | -$8.72M | – |
| Q3 FY2021 | Sep 30, 2021 | -$13.76M | – |
| Q2 FY2021 | Jun 30, 2021 | -$11.98M | – |
| Q1 FY2021 | Mar 31, 2021 | -$10.25M | – |
| Q4 FY2020 | Dec 31, 2020 | -$8.23M | – |
| Q3 FY2020 | Sep 30, 2020 | -$6.95M | – |
See a number that looks wrong?